Project overview

A01 (Lechner/Schmelz): Structure-function properties and markers of silent nociceptors in mice and humans

This project will focus on mechano-insensitive nociceptors, which become sensitized during inflammation. We will utilize optogenetics, cell ablation and DREADD technology in order to study the role of these afferents in pain signalling with electrophysiological recording techniques and behavioural assays. In corresponding human experiments characteristics of silent nociceptors and their sensitization by inflammatory mediators will be studied using microneurography and psychophysics to allow for bidirectional translation.

A02 (Heppenstall): Defining the contribution of C-fibre low threshold mechanoreceptors to nociception, acute pain and pain chronicity

Pleasant, affiliative touch is encoded by a population of peripheral sensory neurons called C-low threshold mechanoreceptors. After injury, these neurons may change their properties and contribute to pain sensations that arise from light touch. We have generated transgenic mouse lines that allow us to identify and manipulate these neurons in vivo. By experimentally silencing or activating these neurons in mice we aim to uncover the role they play in nociceptive processing and understand how they transition from detecting pleasure to pain.

A03 (Nawroth/Pham/Gangadharan): Longitudinal analysis of structural and functional changes in peripheral circuits determining the clinical symptoms of painful diabetic neuropathy

Diabetic polyneuropathy comprises a wide spectrum of painful, but also non-painful symptoms related to structural and functional changes of neural circuits within the peripheral and central neuronal system. Therefore a combined human-mouse approach will be used to describe and understand subtypes of diabetic neuropathy, with the long term goal to pave the way for specific novel therapies.

A04 (Carr/Frings): Structural and functional interactions between nociceptive and non-nociceptive systems within the spinal trigeminal nucleus

Our perception of pain can be modulated by simultaneous activation of other sensory modalities such as smell, touch and temperature. To examine how diverse sensory modalities can impact on pain signalling and behaviour we will explore nociceptive pathways in the trigeminal system. Transgenic and viral tracing techniques will be used to determine anatomical sites of cross-talk with non-nociceptive (e.g. olfactory) signalling pathways. Using optogenetic stimuli, the modulatory effect of olfactory signals on nociceptive processing will be quantified with neuronal recordings and behavioural tests. If we understand the cross-modal pathways in trigeminal nociception, we are in a position to look for treatment.

A05 (Bading/Hagenston/Sprengel): Characteristics and consequences of subcellular calcium signalling in spinal neurons and glia in chronic inflammatory and neuropathic pain

Activity-induced intracellular Ca2+ signaling plays an invaluable role in processes that control persistent adaptations within the CNS. Indeed, Ca2+ signaling in spinal cord neurons, astrocytes, and microglia is strongly implicated in maladaptive pain plasticity. In this study, we will investigate the spatiotemporal features of synaptic activity-triggered Ca2+ signals in distinct subcellular compartments within spinal neuroglial networks, determine whether and how they are altered in chronic pain, and investigate how nuclear Ca2+ signals contribute to the development and maintenance of structural plasticity and nociceptive hypersensitivity in persistent pain models.

A06 (Weidner/Blesch): Functional and structural plasticity following spinal cord injury: contributions to chronic central neuropathic pain

In the proposed studies, we plan to examine structural changes underlying chronic neuropathic pain in spinal cord injury patients and in mouse models of spinal cord injury. Rodent models will take advantage of transgenic animals to label, silence or activate specific neuronal subpopulations. The influence of sensorimotor deprivation versus activation in promoting or reversing the development of pain and its influence on spinal and supraspinal structural plasticity will be examined in parallel in rodents and humans using histology, and electrophysiology and MRI, respectively.

A07 (Siemens): Gene programs in neuronal spinal cord circuits mediating chronic pain states

The proposed project is geared toward a deeper understanding about the neuronal populations involved in processing painful stimuli in the dorsal spinal cord. In particular, we are interested in identifying and characterizing molecular changes that develop in these spinal neurons as a consequence of pathological forms of pain. Subsequently, we aim to elucidate how the identified changes influence the manifestation (and resolution) of pain chronicity using mouse model systems.

A08 (Bading/Mauceri): Epigenetic control of structural and functional plasticity in spinal circuits

Chronic pain is a pathological manifestation of neuronal plasticity in nociceptive pathways. Behavioural changes in chronic pain require gene transcription and are accompanied by structural alterations of synapses. We demonstrated that nuclear calcium governs a transcription program controlling the numbers of dendritic spines in spinal cord neurons. Nuclear calcium tunes transcription also via the modulation of several epigenetic mechanisms. We will study the functional link between pathological pain, epigenetic phenomena, gene expression, and structural remodelling of spinal cord neurons.

B01 (Kuner R.): The role of the prefrontal cortex in nociception and pain and underlying circuitry

Imaging studies in humans implicate the medial prefrontal cortex (mPFC), including the prelimbic and infralimbic cortices (PrL/IL) in pain. However, functional studies are missing. This project aims to address the functional roles of circuits involving the PrL/IL and their bilateral connections with the insular cortex in mice using optogenetics, DREADDs, behavioural assays and in vivo electrophysiological recordings in mouse models of acute and chronic pain. These experiments promise insights on structure-function properties of cortico-cortical circuits and will help reveal how specificity for pain is generated.

B02 (Grinevich/Herpertz): Central oxytocin effects on acute and chronic pain processing

The neuropeptide oxytocin (OXT) is known to act as an endogenous anaesthetic. This tandem project intends to obtain a comprehensive picture of the role of the central OXT system in the modulation of acute and chronic pain in rodents and humans by identifying the neuronal networks involved in OXT-ergic pain modulation. We will dissect the contribution of OXT in pain anticipation and perception as well as in psychological processes underlying chronic pain in humans. The ultimate goal is to provide the anatomical and functional basis for potential use of OXT in the treatment of patients afflicted with chronic pain.

B03 (Nees/Flor): The role of learning, stress and underlying brain circuits involving prefrontal-limbic interactions in the development of chronic back pain

Previous research led to the assumption that chronic pain may be related to emotional learning, however, little is known about the associated changes in brain structure and function that might predict persistent pain. This project seeks to determine brain circuits related to learning mechanisms in pain such as aversive and appetitive, operant and respondent learning as well as the role of stress to predict the transition from acute to chronic back pain and to identify risk and resilience factors.

B04 (Spanagel/Bilbao/Weber-Fahr): Translational studies in chronicity of pain: Neuroplasticity in corticolimbic dopamine and glutamate pathways

It is suggested that the reward circuitry, especially the nucleus accumbens and its glutamatergic input is critical involved in the formation of an aversive affective pain memory. Therefore the key questions we wish to answer in our proposal are: (i) Are different glutamate receptors within the nucleus accumbens critical for the formation and persistence of the negative affective component of pain in mice? (ii) Which structural changes and alterations in functional connectivity occur in the mouse reward system during pain chronification? Only, if we understand the molecular, structural and functional changes induced by chronic pain within the reward circuitry we will be able to deliver adequate treatments to our chronic pain patients.

B05 (Baumgärtner/Draguhn/Rupp): The cortical signature of nociception and pain in circuits of the lateral somatosensory system

This project targets oscillatory evoked and ongoing (spontaneous) responses as a correlate of nociceptive information and pain perception in the brain of rodents and humans. In rodents, multi-units and local field potentials from cortical and thalamic sites will be acquired during phasic, tonic and chronic pain. In humans, specific locations of evoked and ongoing nociceptive activity will be identified using neuroimaging and parallel electro-magnetoencephalographic (EEG-MEG) recordings with aubsequent source analyses and time frequency analyses. In this translational approach cross frequency- and cross regional coupling of oscillatory activity will used to identify a neural signature of nociception and pain.

B06 (Monyer/Kuner R.): Structure-function properties of mouse forebrain local and long-distance GABAergic connections in acute pain and pain chronicity

GABAergic interneurons play a key role in controlling network activity in many forebrain regions. In this study, we will investigate the contribution of local and long-range GABAergic neurons in defined brain circuits that underlie nociception and chronic pain. We will employ mouse genetics to uncouple intra-areal and optogenetics to disrupt inter-areal GABAergic connectivity and will study the effect at the network and behavioural level.

B07 (Flor/Andoh): Neural circuits involved in phantom limb pain

The primary sensorimotor cortices undergo reorganisation after limb amputation and the extent of this change is related to phantom pain. However, we still do not know which factors precede and which follow the pain. This project seeks to determine the development of phantom pain in a longitudinal fashion and will examine how central and peripheral changes as well as psychological factors develop over time. To address these questions we will employ psychological methods, magnetic resonance imaging, transcranial magnetic stimulation and neurofeedback.

B08 (Kuner T.): Causal contributions of structural neuronal plasticity in the cingulate cortex to chronic pain

This project aims at investigating if experience-dependent changes in the dendritic morphology of neurons in the cingulate cortex and axonal projections from the thalamus may underlie the development of chronic pain states. To achieve this, we use chronic two-photon in vivo imaging of fluorescently labelled neurons in mice to follow morphological changes caused by neuropathic pain. Parallel behavioural testing will allow us to relate the pain phenotype to dendritic and axonal structural plasticity.

B09 (Meyer-Lindenberg/Magerl): Plasticity in brain circuits underlying interactions between pain and depression

Project B09 investigates the interaction of depression and pain. It aims at understanding the mechanisms by which depression promotes the development of chronic pain syndromes. The techniques encompass a comprehensive assessment of somatosensory perception in patients with major depression and healthy control subjects, including pain, experimentally-induced pain plasticity and central pain control. The sensory assessments will be combined with magnetic resonance imaging (MRI) techniques to elucidate the functional and structural neural basis that favours chronic pain development in depressed patients.

B10 (Groh): Thalamic processing of pain and putative control by cortical feedback 

The relationship between thalamic sensory processing, cortical feedback and pain perception is not clear, in particular between pathophysiological changes in thalamic activity patterns and the chronicity of pain. We will address thalamic pain processing and its dependency to cortical feedback circuits using electrophysiology, cell-type specific modulation of neuronal activity, and behavioural assays in awake, behaving mice. Understanding pathophysiological changes in thalamic function and regulation that are associated with the development of chronic pain will help us to establish a causal relationship between thalamic operational states and pain perception and will be important for the identification of potential targets for pain treatment.

S01 (Tappe-Theodor/Treede): Standardization and new development of pain-related models and methods in rodents and humans

This project aims to ensure homogeneity of model systems and methods within this SFB. We plan to promote forward and back translation between rodent and human systems. In particular, we aim to develop novel rodent systems for phantom and low back pain, standardize rodent behavioural tests and pain models and develop novel tests for spontaneous pain in rodents and study the impact of anxiety, depression and stress in rodents as well as in humans. Additionally, we plan to validate behavioural and electrophysiological assessment of spinal sensitization and the contribution of the descending pathways in patients.




  • Carmen Ruiz de Almodovar Wins ERC Consolidator Grant

    Congratulations to SFB 1158 Project Leader, Professor Carmen Ruiz de Almodóvar, who has successfully obtained an ERC Consolidator Grant!


    Read more ...  
  • Annual International Research Symposium

    Our Annual International Research Symposium took place on December 3, 2019...

    Read more ...  
  • Bonn Researchers Identify Key Proteins for the Repair of Nerve Fibers

    Prof. Dr. Frank Bradke, and his colleagues at the German Center for Neurodegenerative Diseases (DZNE) have identified a group of proteins that help to regenerate damaged nerve cells.

    Read more ...  
  • Memory engrams discovered in the hypothalamus

    Read more ...  
  • Congratulations!

    The Heidelberg Pain Consortium goes into the second funding period.

    Read more ...